DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Bioactive CompoundsBioactive Compounds
  4. /GPCR & G Protein TargetsGPCR & G Protein Targets
  5. /SSTRSSTR
  6. /PaltusotinePaltusotine
Chemical structure of CAS 2172870-89-0

Paltusotine

In Stock•Starting at $208 for 1 mg•Purity ≥ 98%
CAS No.2172870-89-0
MDL No.N/A
MFC27H22F2N4O
MW456.50
InChI KeyGHILNKWBALQPDP-UHFFFAOYSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT→

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
1 mgTo Be Confirmed$208In Stock
5 mgTo Be Confirmed$559In Stock
10 mgTo Be Confirmed$860In Stock
25 mgTo Be Confirmed$1270In Stock
50 mgTo Be Confirmed$1712In Stock
1 g98%$3344In Stock
5 g98%$10020In Stock
10 g98%$16695In Stock
25 g98%$33386In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.2172870-89-0
Product NamePaltusotine

Biological Targets

SSTR2

Associated Conditions

acromegaly·carcinoid syndrome·neuroendocrine neoplasm
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Paltusotine: First Approval.

Drugs • Vol. 86, Issue 2 • 2026
PMID: 41296264DOI: 10.1007/s40265-025-02260-3

Paltusotine: A Step Toward Precision Medicine in Acromegaly.

The Journal of clinical endocrinology and metabolism • Vol. 110, Issue 3 • 2025
PMID: 39004834DOI: 10.1210/clinem/dgae489

The current status of somatostatin analogs in the treatment of neuroendocrine tumors and future perspectives.

Expert review of neurotherapeutics • Vol. 25, Issue 2 • 2025
PMID: 39415322DOI: 10.1080/14737175.2024.2417419

Treatment of acromegaly with the nonpeptide, highly selective somatostatin receptor type 2 agonist paltusotine.

Best practice & research. Clinical endocrinology & metabolism • Vol. 38, Issue 4 • 2024
PMID: 38845246DOI: 10.1016/j.beem.2024.101906

Documentation

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact